{"name":"Altheus Therapeutics, Inc.","slug":"altheus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ALTH12-1:4","genericName":"ALTH12-1:4","slug":"alth12-1-4","indication":"Other","status":"phase_1"},{"name":"ALTH12-2:4","genericName":"ALTH12-2:4","slug":"alth12-2-4","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ALTH12-1:4","genericName":"ALTH12-1:4","slug":"alth12-1-4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ALTH12-2:4","genericName":"ALTH12-2:4","slug":"alth12-2-4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2014-02-26","type":"trial","source":"Newswise","summary":"Altheus Therapeutics Completes Treatment Portion of ZA201, a Phase 2 Trial of Zoenasa for Ulcerative Colitis | Newswise - Newswise","headline":"Altheus Therapeutics Completes Treatment Portion of ZA201, a Phase 2 Trial of Zoenasa for Ulcerative Colitis | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPMm5pNkVncmQxaGFqV2ZCNHBYY3RONXRZQ1M4QVk2OHY4RzRxNElfX1lCME1qOGtjcjRmUllSdjNnYzBBeG5DQWkwU0FUNk43MTR0MXBxcG5wTW5BTEdhNExFM3l1TW1UeFQ4M2pqZW9iMzVIZC10amhKVkxUZVIzeVJQYWhkR3lUTzMyQzdjVEMwTWpWXzVpMjlTX0VKS2lBaHZQSDN5TU9KZmJCNVZaRlhRLW5hOEE4YXF0S29Vekdpa1BEUXkzTUY4RkJ0YUhjNFBKcmlfNUh4WGVyWHNuTHZURQ?oc=5","date":"2013-11-17","type":"pipeline","source":"The Oklahoman","summary":"Bio Matters: Life Science Fund focuses on Oklahoma discoveries - The Oklahoman","headline":"Bio Matters: Life Science Fund focuses on Oklahoma discoveries","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}